Stuart Evan Seropian MD

Associate Professor of Medicine (Hematology)

Clinical Interests

Hodgkin's disease; Non-Hodgkin's Lymphoma (NHL); multiple myeloma; bone marrow transplant; stem cell transplant


Board Certifications

1997
Medical Oncology, Board Certified

Patient Care Locations

stuart_seropianfaculty-clinicsfalsetruetrue6truefalsefalse

Clinical Trials

ConditionsStudy Title
Hepatic Veno-Occlusive DiseaseDefibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study
Graft Versus Host Disease, Myelodysplastic Syndromes, Leukemia, not otherwise specified, and Non-Hodgkin's LymphomaA Multicenter, Phase II Study of Selective Depletion of CD45RA+ T Cells from Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD
Hepatic Veno-Occlusive Disease, Hodgkin's Lymphoma, Leukemia, not otherwise specified, Multiple Myeloma, and Non-Hodgkin's LymphomaDefibrotide for Patients with Hepatic Veno-Occlusive Disease (VOD): A Treatment IND Study
Limited-stage Diffuse Large B-Cell Lymphoma and Non-Hodgkin's LymphomaA Phase II Trial of PET-Directed Therapy for Limited Stage Diffuse Large B-cell Lymphoma (SWOG S1001)
Leukemia, not otherwise specified and Myeloid and Monocytic LeukemiaA Phase 1-2, Dose Escalation, Multicenter Study of Two Subcutaneous Regimens of SGI-110, a DNA Hypomethylating Agent, in Subjects with Intermediate or High-Risk Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)

More Clinical Trials...

Edit Profile